BRAIN METASTASIS AND HER-2 STATUS IN METASTATIC BREAST CANCER (MBC) IN OMAN

被引:0
|
作者
Monem, E. Abdul [1 ]
Mehdi, I. [1 ]
Al Bahrani, B. [1 ]
机构
[1] Royal Hosp, Muscat, Oman
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
121P
引用
收藏
页码:48 / 48
页数:1
相关论文
共 50 条
  • [21] HER-2/neu expression in primary and metastatic breast cancer
    Lower, Elyse E.
    Glass, Eleanor
    Blau, Robbin
    Harman, Stacy
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 113 (02) : 301 - 306
  • [22] HER-2 STATUS CORRELATION BETWEEN PRIMARY BREAST CANCER AND CORRESPONDING DISTANT METASTATIC SITES
    Frahm, I.
    Acosta Haab, G.
    Sanchez Marull, R.
    Sarancone, S.
    Caceres, V.
    ANNALS OF ONCOLOGY, 2010, 21 : 102 - 102
  • [23] Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites
    Gancberg, D
    Di Leo, A
    Cardoso, F
    Rouas, G
    Pedrocchi, M
    Paesmans, M
    Verhest, A
    Bernard-Marty, C
    Piccart, MJ
    Larsimont, D
    ANNALS OF ONCOLOGY, 2002, 13 (07) : 1036 - 1043
  • [24] Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer
    Gaedcke, Jochen
    Traub, Frank
    Milde, Simone
    Wilkens, Ludwig
    Stan, Alexandru
    Ostertag, Helmut
    Christgen, Mathias
    von Wasielewski, Reinhard
    Kreipe, Hans H.
    MODERN PATHOLOGY, 2007, 20 (08) : 864 - 870
  • [25] Metastatic patterns and outcomes by HER2 and hormone receptor (HR) status in patients (pts) with metastatic breast cancer (mBC)
    Yuan, Qianyu
    Castellanos, Emily
    Fidyk, Erin
    Schwed, Karen
    Estevez, Melissa
    Nemeth, Sheila
    Linzmayer, Robin
    Cohen, Aaron B.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Lapatinib prevents metastatic colonization of EGFR and Her-2 overexpressing breast cancer cells in the brain
    Gril, Brunilde
    Palmieri, Diane
    Hua, Emily K.
    Vega-Valle, Eleazar
    Herring, Jeanne
    Feigenbaum, Lionel
    Liewehr, David J.
    Steinberg, Seth M.
    Rubin, Stephen D.
    Steeg, Patricia S.
    CLINICAL & EXPERIMENTAL METASTASIS, 2009, 26 (07) : 880 - 880
  • [27] Estrogen receptor (ER) status and survival outcomes in HER2 positive (+) metastatic breast cancer (mBC).
    DeSouza, Karen
    Zammit, Rosa-Rita
    Haire, Anna
    Sinha, Rajesh
    Simcock, Richard
    Moss, Charlotte Hannah
    Mera, Anca
    Mansi, Janine
    Karapanagiotou, Eleni
    Sawyer, Elinor
    Patel, Gargi Surendra
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [28] Assessment of HER-2 status in invasive breast cancer in Brazil
    Arrua Arias, Victor Eduardo
    Gobbi, Helenice
    Ioshii, Sergio Ossamu
    Scapulatempo, Cristovam
    da Paz, Alexandre Rolim
    da Silva, Vinicius Duval
    Uchoa, Diego
    Zettler, Claudio
    Soares, Fernando Augusto
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (07): : 566 - 574
  • [29] Her-2 status in breast cancer patients with orbital metastases
    Albrecht, S.
    Zilli, T.
    Popowski, Y.
    Balmer, Majno S.
    Weber, D. C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 172 - 172
  • [30] HER-2 Status May Change in Recurrent Breast Cancer
    Arnaout, K.
    Khalife, M.
    Younes, M.
    Hanbali, A.
    CANCER RESEARCH, 2009, 69 (24) : 802S - 802S